Citations 1
Academic and Community Cancer Research United (ACCRU) RU011301I: Adjuvant ado-trastuzumab emtansine (T-DM1) for older patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer.
Polley, Mei‐Yin C. , Hurria, Arti , Muss, Hyman B. , Ruddy, Kathryn J. , Liu, Heshan , Rogak, Lauren J. , Basch, Ethan , Dakhil, Shaker R. , Huff, Jason D., Bajaj, Madhuri, Wilkinson, Mary, Baghadadi, Tareq Al, Benjamin, Sam, Mowat, Rex B., Hudis, Clifford A. , Freedman, Rachel A. , Dueck, Amylou C. , Hubbard, Joleen M. , Basch, Ethan , Rugo, Hope S. , Winer, Eric P. , Baghdadi, Tareq Al
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: TPS629-TPS629
